229 related items for PubMed ID: 20196386
21. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
[Abstract] [Full Text] [Related]
22. Factors predicting final height in early treated congenital hypothyroid patients.
Delvecchio M, Salerno M, Acquafredda A, Zecchino C, Fico F, Manca F, Faienza MF, Cavallo L.
Clin Endocrinol (Oxf); 2006 Nov; 65(5):693-7. PubMed ID: 17054475
[Abstract] [Full Text] [Related]
23. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF, McNeill E, Young D, Donaldson MD.
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[Abstract] [Full Text] [Related]
24. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
Horm Res Paediatr; 2018 Nov; 89(1):7-12. PubMed ID: 29073619
[Abstract] [Full Text] [Related]
25. Adult height of patients with classical congenital adrenal hyperplasia.
Tung YC, Lee JS, Tsai WY, Hsiao PH.
J Formos Med Assoc; 2005 Feb; 104(2):133-6. PubMed ID: 15765171
[Abstract] [Full Text] [Related]
26. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Feb; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
27. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
Horm Res; 2001 Feb; 55(4):161-71. PubMed ID: 11598369
[Abstract] [Full Text] [Related]
28. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
[Abstract] [Full Text] [Related]
29. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S, Zemková D, Snajderová M, Lebl J.
Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
[Abstract] [Full Text] [Related]
30. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis.
Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH.
J Pediatr; 2001 Jan 01; 138(1):26-32. PubMed ID: 11148508
[Abstract] [Full Text] [Related]
31. [Adult height, pattern of growth and pubertal development in patients with congenital adrenal hyperplasia, salt losing form].
Gussinyé M, Potau N, Vicens-Calvet E, Albisu MA, Yeste D, Ibáñez L, Audí L, Carrascosa A.
Med Clin (Barc); 1997 Jan 25; 108(3):87-90. PubMed ID: 9064437
[Abstract] [Full Text] [Related]
32. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
Arch Dis Child; 2002 Aug 25; 87(2):139-44. PubMed ID: 12138066
[Abstract] [Full Text] [Related]
33. Final height and its predictive factors after renal transplantation in childhood.
Hokken-Koelega AC, van Zaal MA, van Bergen W, de Ridder MA, Stijnen T, Wolff ED, de Jong RC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Drop SL.
Pediatr Res; 1994 Sep 25; 36(3):323-8. PubMed ID: 7808828
[Abstract] [Full Text] [Related]
34. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
[Abstract] [Full Text] [Related]
35. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov 01; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
36. Growth pattern of childhood thyrotoxicosis: longitudinal follow-up to final height.
Jaruratanasirikul S, Sriplung H.
J Med Assoc Thai; 2006 Sep 01; 89(9):1396-9. PubMed ID: 17100375
[Abstract] [Full Text] [Related]
37. Growth and final height after liver transplantation during childhood.
Scheenstra R, Gerver WJ, Odink RJ, van Soest H, Peeters PM, Verkade HJ, Sauer PJ.
J Pediatr Gastroenterol Nutr; 2008 Aug 01; 47(2):165-71. PubMed ID: 18664868
[Abstract] [Full Text] [Related]
38. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.
Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fékété C, Morel Y, Brauner R.
J Clin Endocrinol Metab; 2003 Jun 01; 88(6):2624-33. PubMed ID: 12788866
[Abstract] [Full Text] [Related]
39. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty.
Wehkalampi K, Vangonen K, Laine T, Dunkel L.
Horm Res; 2007 Jun 01; 68(2):99-104. PubMed ID: 17377395
[Abstract] [Full Text] [Related]
40. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
Hilczer M, Smyczyńska J, Lewiński A.
Neuro Endocrinol Lett; 2006 Jun 01; 27(1-2):149-52. PubMed ID: 16648787
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
